Fan, R., Sun, J., Yuan, Q., Xie, Q., Bai, X., Ning, Q., . . . Hou, J. (2016). Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues. Gut.
Styl cytowania ChicagoFan, Rong, et al. "Baseline Quantitative Hepatitis B Core Antibody Titre Alone Strongly Predicts HBeAg Seroconversion Across Chronic Hepatitis B Patients Treated With Peginterferon or Nucleos(t)ide Analogues." Gut 2016.
Styl cytowania MLAFan, Rong, et al. "Baseline Quantitative Hepatitis B Core Antibody Titre Alone Strongly Predicts HBeAg Seroconversion Across Chronic Hepatitis B Patients Treated With Peginterferon or Nucleos(t)ide Analogues." Gut 2016.